1,3-dipropyl-8-cyclopentylxanthine has been researched along with sk&f-38393 in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (16.67) | 18.2507 |
2000's | 5 (83.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
Austin, CP; Fidock, DA; Hayton, K; Huang, R; Inglese, J; Jiang, H; Johnson, RL; Su, XZ; Wellems, TE; Wichterman, J; Yuan, J | 1 |
di Chiara, G; Morelli, M; Pinna, A; Wardas, J | 1 |
Reinart, R; Rinken, A; Uustare, A | 1 |
Cao, Y; Jin, L; Sun, WC; Xie, KQ; Zhu, XZ | 1 |
Cao, Y; Xie, KQ; Zhu, XZ | 1 |
6 other study(ies) available for 1,3-dipropyl-8-cyclopentylxanthine and sk&f-38393
Article | Year |
---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum.
Topics: Animals; Antimalarials; ATP Binding Cassette Transporter, Subfamily B, Member 1; Chromosome Mapping; Crosses, Genetic; Dihydroergotamine; Drug Design; Drug Resistance; Humans; Inhibitory Concentration 50; Mutation; Plasmodium falciparum; Quantitative Trait Loci; Transfection | 2009 |
Blockade of A2a adenosine receptors positively modulates turning behaviour and c-Fos expression induced by D1 agonists in dopamine-denervated rats.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Denervation; Male; Motor Activity; Nerve Tissue Proteins; Oxidopamine; Proto-Oncogene Proteins c-fos; Purinergic P1 Receptor Antagonists; Pyrimidines; Quinazolines; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Rotation; Triazoles; Xanthines | 1996 |
Modulation of dopamine D1 receptor signaling by adenosine A1 receptors in Sf9 cells requires expression of Gi proteins.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Adenosine; Adenosine A1 Receptor Antagonists; Animals; Benzazepines; Binding, Competitive; Cell Line; Cyclic AMP; Dopamine Agonists; Dopamine Antagonists; Dose-Response Relationship, Drug; Drug Interactions; Gene Expression; GTP-Binding Protein alpha Subunits, Gi-Go; Guanosine 5'-O-(3-Thiotriphosphate); Humans; Radioligand Assay; Receptor, Adenosine A1; Receptors, Dopamine D1; Signal Transduction; Spodoptera; Transfection; Tritium; Xanthines | 2006 |
Activation of adenosine A1 receptor modulates dopamine D1 receptor activity in stably cotransfected human embryonic kidney 293 cells.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Adenosine; Adenosine A1 Receptor Agonists; Adenosine A1 Receptor Antagonists; Alkaline Phosphatase; Benzazepines; Cell Line; Cyclic AMP Response Element-Binding Protein; DNA, Complementary; Dopamine Agonists; Dopamine Antagonists; Humans; Receptor, Adenosine A1; Receptors, Dopamine D1; Transfection; Xanthines | 2006 |
The enhancement of dopamine D1 receptor desensitization by adenosine A1 receptor activation.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Adenosine; Binding, Competitive; Cell Line; Cyclic AMP; Dopamine Agonists; Drug Synergism; Humans; Receptor, Adenosine A1; Receptors, Dopamine D1; Time Factors; Transfection; Xanthines | 2007 |